BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28946549)

  • 1. Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway.
    Wang J; Ma W; Liu Y
    Cancer Biomark; 2017 Dec; 20(4):425-434. PubMed ID: 28946549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
    Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA HULC promotes cell proliferation by regulating PI3K/AKT signaling pathway in chronic myeloid leukemia.
    Lu Y; Li Y; Chai X; Kang Q; Zhao P; Xiong J; Wang J
    Gene; 2017 Apr; 607():41-46. PubMed ID: 28069548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
    Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
    Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA HULC promotes proliferation, migration and invasion of pancreatic cancer cells by down-regulating microRNA-15a.
    Feng H; Wei B; Zhang Y
    Int J Biol Macromol; 2019 Apr; 126():891-898. PubMed ID: 30593805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas.
    Zhu Y; Zhang X; Qi L; Cai Y; Yang P; Xuan G; Jiang Y
    Oncotarget; 2016 Mar; 7(12):14429-40. PubMed ID: 26894862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
    Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
    Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of DUXAP10 inhibits proliferation and promotes apoptosis in bladder cancer cells via PI3K/Akt/mTOR signaling pathway.
    Lv XY; Ma L; Chen JF; Yu R; Li Y; Yan ZJ; Cheng Y; Ma Q
    Int J Oncol; 2018 Jan; 52(1):288-294. PubMed ID: 29115412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
    Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HULC targets the IGF1R-PI3K-AKT axis in trans to promote breast cancer metastasis and cisplatin resistance.
    Zhou L; Li H; Sun T; Wen X; Niu C; Li M; Li W; Hoffman AR; Hu JF; Cui J
    Cancer Lett; 2022 Nov; 548():215861. PubMed ID: 35981570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HULC functions as an oncogene in ovarian carcinoma cells by negatively modulating miR-125a-3p.
    Chu P; Xu L; Su H
    J Physiol Biochem; 2019 Jun; 75(2):163-171. PubMed ID: 30863948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
    Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
    Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway.
    Zhu H; Li X; Song Y; Zhang P; Xiao Y; Xing Y
    Biochem Biophys Res Commun; 2015 Nov; 467(2):223-8. PubMed ID: 26449463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA PlncRNA-1 Promotes Colorectal Cancer Cell Progression by Regulating the PI3K/Akt Signaling Pathway.
    Song W; Mei JZ; Zhang M
    Oncol Res; 2018 Mar; 26(2):261-268. PubMed ID: 28835319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lncRNA HULC knockdown on rat secreting pituitary adenoma GH3 cells.
    Rui QH; Ma JB; Liao YF; Dai JH; Cai ZY
    Braz J Med Biol Res; 2019; 52(4):e7728. PubMed ID: 30994730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
    Lv S; Wang W; Wang H; Zhu Y; Lei C
    BMC Cancer; 2019 Mar; 19(1):204. PubMed ID: 30845932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
    Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.